DEF: Aeluma's 2025 Annual Meeting & Strong Q1 Revenue Growth
Preliminary Proxy Statement and Financial Reports
Aeluma, Inc. announces its 2025 Annual General Meeting of Shareholders to elect directors and ratify auditors, alongside reporting significant revenue growth and successful capital raises.
Summary
- The 2025 Annual General Meeting of Shareholders will be held virtually on Thursday, January 15, 2026, at 9:00 a.m. PST.
- Shareholders will vote on two proposals: the election of Class I directors (Steven P. DenBaars and John Paglia) for 3-year terms, and the re-appointment of Rose, Snyder & Jacobs LLP as the company's independent auditors for the fiscal year ending June 30, 2026.
- The Board of Directors unanimously recommends voting 'FOR' both proposals.
- The record date for determining shareholders entitled to vote at the 2025 Annual Meeting is November 21, 2025, with 17,857,863 shares of common stock outstanding.
- Revenue for the fiscal year ended June 30, 2025, increased by $3.7 million (407.9%) to $4.7 million, primarily from government contracts.
- Revenue for the three months ended September 30, 2025 (Q1 FY2026), increased by $904 thousand (187.9%) to $1.4 million compared to the same period in 2024.
- The net loss for FY2025 was $(3.0) million, an improvement from $(4.6) million in FY2024.
- The net loss for Q1 FY2026 was $(1.5) million, compared to $(0.7) million in Q1 FY2025.
- Cash, cash equivalents, and a certificate of deposit totaled $38.1 million as of September 30, 2025, a significant increase from $15.7 million as of June 30, 2025.
- The company successfully completed public offerings in March 2025, raising $12.6 million net, and in September 2025, raising $23.4 million net.
- Management believes that the successful capital raises have alleviated 'substantial doubt about our ability to continue as a going concern' for at least the next twelve months.
- A material weakness in internal control over financial reporting was identified as of June 30, 2025, due to an insufficient number of personnel with appropriate technical accounting and SEC reporting expertise.
Sentiment
Score: 7
Explanation: The company shows strong revenue growth and has significantly improved its financial position through successful capital raises, alleviating going concern doubts. However, it continues to incur net losses and has identified material weaknesses in internal controls, indicating ongoing operational challenges typical of an early-stage company.
Positives
- Significant revenue growth: $4.7 million in FY2025 (407.9% increase) and $1.4 million in Q1 FY2026 (187.9% increase).
- Reduced net loss in FY2025 to $(3.0) million from $(4.6) million in FY2024.
- Strong cash position: $38.1 million as of September 30, 2025, providing substantial liquidity.
- Successful public offerings in March 2025 ($12.6 million net) and September 2025 ($23.4 million net) significantly bolstered capital.
- Alleviation of 'substantial doubt about ability to continue as a going concern' due to recent capital raises.
- Secured multiple government contracts totaling $13.8 million in FY2025 and an additional $150 thousand in Q1 FY2026, demonstrating strong R&D traction.
- Expansion of R&D and manufacturing facilities with a new 2,400 sq. ft. office space to accommodate anticipated headcount growth.
- Appointment of Christopher Stewart as full-time Chief Financial Officer in August 2025, bringing public company experience.
Negatives
- Continued net losses: $(3.0) million in FY2025 and $(1.5) million in Q1 FY2026, indicating ongoing unprofitability.
- Increased operating expenses: $6.8 million in FY2025 (24.2% increase) and $3.0 million in Q1 FY2026 (146.9% increase), outpacing revenue growth in Q1 FY2026.
- Net cash used in operating activities: $(1.1) million in FY2025 and $(0.8) million in Q1 FY2026, despite revenue growth.
- Q1 FY2026 net loss of $(1.5) million is higher than Q1 FY2025 net loss of $(0.7) million.
- Identified material weakness in internal control over financial reporting as of June 30, 2025, due to insufficient personnel with appropriate technical accounting and SEC reporting expertise.
Risks
- The company is in early development stages with limited operating history and no volume production for product offerings, making business prospects difficult to evaluate.
- Uncertainty in achieving and sustaining profitability, with a history of net losses and negative cash flows from operations.
- Failure to raise additional capital or generate sufficient cash flows could limit operations and growth.
- Inability to successfully implement its growth strategy on a timely basis or at all, including expanding partnerships, acquiring customers, and scaling technology.
- Timelines for technology adoption might be longer than anticipated, delaying revenue growth.
- Changes to regulatory agencies (e.g., DOGE) could impact business operations and financial outlook through funding reductions or delays.
- Compliance with federal securities laws and Nasdaq requirements is increasingly complex and expensive, potentially diverting management attention.
- Dependence on U.S. federal government contracts, which are subject to competitive bidding, budgetary cycles, and termination for convenience.
- Reliance on the management team and other key employees; loss of personnel or inability to attract qualified staff could harm the business.
- Inaccurate estimates or judgments relating to critical accounting policies could adversely affect results of operations.
- Changes in accounting rules and regulations, or interpretations thereof, could result in unfavorable accounting charges.
- Ability to use net operating loss carryforwards and other tax attributes may be limited by ownership changes.
- Dependence on a limited number of customers, with the loss of one or more potentially having a material adverse effect.
- Some business may be dependent on a royalty-based model, which is inherently risky and subject to various external factors.
- Uncertainties regarding the timing and amount of customer orders could lead to excess inventory and write-downs.
- Products may require a lengthy and expensive qualification process without assurance of product sales.
- Business operations could suffer from information technology systems failures or security breaches.
- Failure to protect and enforce intellectual property rights and confidential information could weaken the competitive position.
- Technologies may infringe on the intellectual property rights of others, leading to costly disputes or disruptions.
- Inability to effectively manage growth by implementing and improving operational and financial systems.
- Inaccurate estimates related to expenditures could lead to business failure.
- Inadequate insurance coverage for significant risk exposures.
- Potential for product liability lawsuits, warranty claims, and product recalls.
- Litigation from time to time during the normal course of business could adversely affect financial condition.
- Natural disasters, public health crises, political crises, economic downturns, or other unexpected events could disrupt operations and supply chain.
- Current operations are concentrated in one location (Santa Barbara, California), increasing vulnerability to disasters.
- Conflicts of interest due to officers and directors allocating time to other businesses.
- Reliance on limited sources of wafer fabrication, packaged products fabrication, and product testing.
- Susceptibility to manufacturing delays and pricing fluctuations from third-party manufacturers.
- Downturns or volatility in general economic conditions could reduce customer demand.
- The semiconductor industry is highly cyclical, leading to significant downturns and upturns in demand.
- Rapid innovation and short product life cycles in the semiconductor industry can result in price erosion of older products.
- Shortages or increased prices of raw materials, including rare earths or rare minerals, could adversely affect results.
- Changes in import tariffs due to new administrations could impact the semiconductor industry.
- Interdependent facilities and an operational disruption at any particular facility could materially affect product production.
- Inability to maintain manufacturing efficiency could adversely affect results of operations.
- Failure to successfully implement cost reduction initiatives could adversely affect business.
- Inability to identify and make substantial R&D investments required to remain competitive.
- Inability to develop new products to satisfy changing customer demands or regulatory requirements.
- The semiconductor industry is highly competitive, and inability to compete effectively could adversely affect business.
- Rapid consolidation in the semiconductor industry could disadvantage the company against larger competitors.
- Dependence on third-party suppliers and contract manufacturers, with risks of disruption or quality deterioration.
- Sales through distributors and other third parties expose the company to additional risks.
- Potential future global operations may subject the company to risks inherent in doing business on a global level.
- Special authorizations, permits, and licenses may be required for operations, which if delayed or denied could adversely affect results.
- Environmental and health and safety liabilities and expenditures could materially adversely affect results.
- Disruptions or breaches of the secured network could damage reputation and business.
- Failure to comply with the terms and conditions of contracts, especially government contracts, could result in liabilities.
- As a smaller reporting company, reduced disclosure requirements may make common stock less attractive to investors.
- Limitations on the effectiveness of internal controls, even if established, could lead to error or fraud.
- Officers, directors, and 5%+ stockholders own a significant percentage of voting securities, potentially reducing minority stockholder influence.
- No intention to pay dividends on common stock in the foreseeable future, relying on price appreciation for investor returns.
- Potential for penny stock regulations and restrictions, making it difficult to sell shares.
- Substantial future sales of common stock could cause the market price to decline.
- Lack of research or reports from securities or industry analysts could reduce stock price and trading volume.
- Provisions in amended and restated certificate of incorporation and bylaws, and Delaware law, may inhibit a takeover.
- Bylaws require derivative actions to be brought in the Court of Chancery in Delaware, potentially discouraging lawsuits.
- Upon dissolution, investors may not recoup all or any portion of their investment.
- The market price and trading volume of common stock may be volatile.
- Risks related to securities litigation could result in significant legal expenses and awards.
- FINRA sales practice requirements may limit a stockholder's ability to buy and sell the stock.
- Inability to comply with the continued listing requirements of The Nasdaq Capital Market could lead to delisting.
- A prolonged U.S. federal government shutdown could materially and adversely affect business, operations, and legal proceedings.
- Federal budget and debt-ceiling disputes may adversely affect capital markets and financing activities.
Future Outlook
The company plans to continue developing its technology, focusing on manufacturing high-performance semiconductor technologies that scale for mass markets. It will mature manufacturing processes, expand business development and marketing efforts, further engage with manufacturing partners, and continue efforts toward volume production and commercialization. Based on the current operating plan, existing cash, cash equivalents, and certificate of deposit, combined with projected revenues and cost management strategies, are expected to be sufficient to meet working capital and capital expenditure requirements for at least the next twelve months. The company will continue to assess capital requirements and may pursue additional financing opportunities.
Management Comments
- "We are excited to continue to utilize the latest technology to provide expanded access, improved communication, and cost savings for our shareholders. Hosting a virtual meeting this year will enable increased shareholder attendance and participation, since our shareholders can participate from any location around the world."
- "Aeluma aims to break out of traditional manufacturing to expand the reach of its technology into mass markets. The demand for higher-performance semiconductors in consumer markets is increasing (Aeluma's disruptive technology is scalable, cost-effective, while not sacrificing performance."
- "With the successful completion of the offerings, we believe that substantial doubt about our ability to continue as a going concern has been alleviated for at least the next twelve months."
- "Our current staffing resources in our finance department are insufficient to support the complexity of our financial reporting requirements. As a result, we have had an inadequate level of precision, evidence or timeliness in the performance of review controls. Our management team is in the process of implementing remediation measures. As of this filing, we have hired a chief financial officer with public company financial reporting experience, and are planning to add qualified accounting personnel and enhance our internal control processes and documentation."
Industry Context
Aeluma operates in the highly competitive and cyclical semiconductor industry, characterized by rapid innovation and short product life cycles. The company's technology aims to disrupt the image sensor market by enabling cost-effective manufacturing of high-performance compound semiconductors on large-diameter substrates, positioning it to potentially outperform silicon CMOS sensors and achieve lower costs than traditional InGaAs sensors. Aeluma targets high-growth sectors such as mobile, automotive, AI, defense & aerospace, communication, augmented reality (AR), virtual reality (VR), high-performance computing, and quantum computing, with these markets projected to reach hundreds of billions to trillions of dollars by 2030. The industry is experiencing consolidation, and Aeluma faces competition from major global players like Sony, Samsung, and Hamamatsu, as well as smaller niche companies. The company's strategy involves leveraging its unique manufacturing capabilities and extensive patent protection to scale production for mass markets.
Comparison to Industry Standards
- Aeluma's technology aims to outperform silicon CMOS image sensors by offering higher detection sensitivity and a broader wavelength absorption spectrum, extending into the shortwave infrared (SWIR) range (900-1700 nm), which is considered eye-safe, unlike the near-infrared cutoff of silicon (near 940 nm).
- The company believes its technology can achieve a manufacturing cost potentially ten times lower than traditional InGaAs sensors by utilizing larger diameter substrates (up to 12-inch) compared to the typical 2to 4-inch indium phosphide (InP) substrates used by competitors like Hamamatsu, Sumitomo, Teledyne/FLIR, and Excelitas.
- Aeluma's ability to manufacture on larger substrates allows for much larger area photodetector arrays and leverages wafer-scale integration and packaging available for 8and 12-inch substrates, enabling faster scaling to meet mass market demands.
- In the mobile market, Apple's deployment of VCSEL emitters with single-photon avalanche diode (SPAD) photodetectors for facial identification and lidar sensing sets a high benchmark for advanced capabilities, which Aeluma's technology aims to address for next-generation applications.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer/Principal Accounting Officer | James Seo (Interim) | Christopher Stewart | August 4, 2025 | Appointment of a full-time CFO with public company financial reporting experience. |
| Vice President of Finance Operations & Systems (NVIDIA) | Michael Byron | N/A | December 2024 | Retired from NVIDIA; continues as an Aeluma director. |
| Faculty Member, Pepperdine University's Graziadio School of Business | John Paglia | N/A | July 2025 | Retired with honorary title Professor Emeritus of Finance; continues as an Aeluma director. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- No material litigation, arbitration, governmental proceeding, or any other legal proceeding is currently pending or known to be contemplated against the company or its management team.
- Christopher Stewart, the newly appointed CFO, was the Chief Financial Officer of LeddarTech Holdings, Inc. and a director of VayaVision Sensing Ltd. when both entities voluntarily filed for bankruptcy in June and July 2025, respectively.
Related Party Transactions
- An Advisory Agreement with director Steven DenBaars, dated December 31, 2020, granted him the right to purchase 32,805 shares of common stock at $0.008 per share, which he purchased on February 4, 2021.
- An amended Advisory Agreement with Steven DenBaars, dated June 10, 2021, granted him the right to purchase an additional 213,198 shares of common stock at $0.015 per share; 241,903 shares have vested as of the report date.
- Steven DenBaars purchased 33,333 shares of common stock in a private financing between December 2022 and May 2023 at $3 per share, on the same terms as other investors.
- Jonathan Klamkin (CEO and Director) beneficially owned 1,600,234 shares (10.0%) as of September 7, 2025.
- Steven P. DenBaars (Director) beneficially owned 516,864 shares (3.2%) as of September 7, 2025.
- John Paglia (Director) beneficially owned 260,518 shares (1.6%) as of September 7, 2025.
- Mark Tompkins (5%+ stockholder) beneficially owned 2,715,833 shares (17.1%) as of September 7, 2025.
- Lee McCarthy (5%+ stockholder) beneficially owned 977,425 shares (6.2%) as of September 7, 2025.
Stakeholder Impact
- Shareholders will participate in the annual meeting to elect directors and ratify auditors, influencing corporate governance. Recent equity offerings have caused dilution but also significantly strengthened the company's financial position, alleviating going concern risks.
- Employees benefit from stock-based compensation and new hires to support business expansion, but the company faces challenges in attracting and retaining personnel due to high local housing costs.
- Customers, particularly government agencies, benefit from ongoing R&D, product development, and efforts to scale manufacturing, with significant revenue derived from government contracts.
- Suppliers and manufacturing partners are crucial for scaling production, and the company's reliance on limited sources and potential geopolitical impacts on raw materials could affect these relationships.
- Creditors have seen convertible notes converted to equity, reducing the company's debt obligations and improving its balance sheet.
Next Steps
- Hold the 2025 Annual General Meeting of Shareholders on January 15, 2026, to vote on director elections and auditor re-appointment.
- Continue to develop technology, including novel materials and devices, with a primary focus on high-performance semiconductor manufacturing that scales for mass markets.
- Mature manufacturing processes to further commercialization traction.
- Expand business development and marketing efforts, and further engage with manufacturing partners.
- Continue efforts toward volume production and commercialization.
- Hire additional qualified accounting personnel and enhance internal control processes and documentation to remediate identified material weaknesses.
- Mr. DenBaars has adopted a new Rule 10b5-1 trading arrangement for sales between February 25, 2026, and November 19, 2026.
- Shareholder proposals for the 2026 Annual Meeting must be submitted by July 25, 2026.
Key Dates
| Date | Description |
|---|---|
| December 31, 2020 | Advisory Agreement with Mr. DenBaars. |
| February 4, 2021 | Mr. DenBaars purchased 32,805 shares of common stock. |
| April 1, 2021 | Commencement of 5-year operating lease for a facility in Goleta, California. |
| June 5, 2021 | Steven P. DenBaars joined Biond Photonics (now Aeluma) Board of Directors. |
| June 10, 2021 | Advisory Agreement with Mr. DenBaars amended, granting the right to purchase an additional 213,198 shares. |
| June 22, 2021 | Certificate of Merger filed, and Amended and Restated certificate of incorporation and bylaws became effective. |
| July 1, 2021 | Rent payments commenced for the Goleta facility lease. |
| November 30, 2021 | John Paglia joined as a director and chair of the audit committee. |
| January 1, 2022 | Number of shares reserved for the 2021 Equity Incentive Plan increased by 532,500. |
| August 26, 2022 | Common stock began trading on the OTCQB system under the symbol ALMU. |
| November 30, 2022 | Mr. Klamkin granted a stock option to purchase 100,000 shares of common stock. |
| December 2022 May 2023 | Steven DenBaars purchased 33,333 shares of common stock in a private financing at $3 per share. |
| January 1, 2023 | Number of shares reserved for the 2021 Equity Incentive Plan increased by 565,850. |
| May 15, 2023 | Mr. Seo granted a stock option to purchase 40,000 shares of common stock. |
| July 1, 2023 | One of the two options to extend the Goleta facility lease was considered reasonably certain of exercise, leading to remeasurement of ROU asset and lease liability. |
| September 10, 2023 | The company exercised its option to purchase 649,570 unvested restricted shares held by Lee McCarthy. |
| January 10, 2024 | The Board approved issuing Mr. Klamkin 220,000 options and granted stock options to Mr. DenBaars (84,663), Mr. Ensley (85,885), and Mr. Paglia (87,973). |
| August 5, 2024 August 27, 2024 | Issued convertible promissory notes in the aggregate principal amount of $3.1 million to 10 accredited investors. |
| August 2024 | Received a contract by NASA to develop quantum dot photonic integrated circuits (PICs) on silicon. |
| September 27, 2024 | Board meeting held. |
| September 2024 | Received an $11.7 million contract with DARPA to develop heterogeneous integration technology. |
| November 6, 2024 | Board meeting held. |
| December 31, 2024 | Aggregate market value of common stock held by non-affiliates was approximately $77.8 million. |
| January 1, 2025 | Number of shares reserved for the 2021 Equity Incentive Plan increased by 612,124; Board approved issuing Mr. Seo 15,000 options. |
| January 27, 2025 | The Board of Directors approved an increase in Mr. Klamkin's annual salary to $295,000. |
| February 6, 2025 | Board meeting held. |
| February 10, 2025 | Entered into an independent director agreement with Mr. Byron, issuing him 45,833 stock options. |
| February 24, 2025 | Michael Byron began serving as a director. |
| March 18, 2025 | Mr. James Seo agreed to serve as the company's interim Chief Financial Officer/Principal Accounting Officer. |
| March 25, 2025 | A Conversion Event occurred for convertible notes, leading to the conversion of $3.1 million in principal into 898,573 shares of common stock at $3.50 per share. The Form S-1 registration statement was declared effective. |
| March 26, 2025 | Entered into an Underwriting Agreement for a public offering of 2,285,714 shares at $5.25 per share. Common stock began trading on the Nasdaq Capital Market under the symbol ALMU. |
| March 27, 2025 | The Underwriter exercised its 30-day option to purchase an additional 342,857 shares. |
| March 28, 2025 | The public offering closed. |
| April 2025 | Received a contract with the U.S. Department of Energy to develop commercially viable, low-cost shortwave infrared (SWIR) photodetectors. |
| May 6, 2025 | Board meeting held. |
| May 14, 2025 | Mr. Jonathan Klamkin adopted a non-Rule 10b5-1 trading arrangement. |
| June 6, 2025 | Entered into a lease agreement for additional corporate office space in Goleta, California. |
| June 2025 | Received a contract with the U.S. Navy to accelerate development of high-speed photodetectors. |
| June 2025 | Received a contract with the U.S. Navy to accelerate development and commercialization for next-generation quantum computing and sensing systems. |
| June 23, 2025 | Mr. Steven DenBaars adopted a Rule 10b5-1 trading arrangement. |
| July 2025 | John Paglia retired from Pepperdine University with the honorary title of Professor Emeritus of Finance. |
| July 31, 2025 | Filed a registration statement on Form S-3 with the SEC, using a shelf registration process. |
| August 4, 2025 | Christopher Stewart was appointed as Chief Financial Officer/Principal Accounting Officer, replacing Mr. James Seo. |
| August 6, 2025 | Amended the shelf registration statement on Form S-3. |
| August 8, 2025 | The shelf registration statement on Form S-3 was declared effective. |
| August 14, 2025 | 150,000 shares were sold under Mr. Klamkin's trading plan. |
| August 18, 2025 | Mr. Klamkin terminated his trading plan. |
| September 5, 2025 | Conditions for the new Goleta office lease were met, making it non-cancellable, and the lease commenced. |
| September 7, 2025 | There were 15,892,887 shares of common stock outstanding. |
| September 9, 2025 | Annual Report on Form 10-K for the fiscal year ended June 30, 2025, was filed with the SEC. |
| September 16, 2025 | Mr. DenBaars terminated his Rule 10b5-1 Plan. |
| September 17, 2025 | Entered into an Underwriting Agreement for a public offering of 1,700,000 shares at $13.00 per share. |
| September 18, 2025 | Underwriters exercised their option to purchase an additional 255,000 shares of common stock in the September offering. A prospectus supplement and accompanying prospectus were filed with the SEC. |
| September 19, 2025 | The September public offering closed. |
| September 21, 2025 | The company commenced a 5-year operating lease for an office in Goleta, California. |
| November 10, 2025 | There were 17,857,863 shares of the issuer's common stock outstanding. |
| November 12, 2025 | Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, was filed with the SEC. |
| November 21, 2025 | Record date for the 2025 Annual Meeting. Mr. DenBaars adopted a new Rule 10b5-1 trading arrangement. |
| December 2, 2025 | Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting mailed to shareholders. |
| January 13, 2026 | Proxy card must be postmarked by 3:00 pm EST to be counted. |
| January 14, 2026 | Internet and telephone votes must be received by 11:59 p.m. EST to be counted. |
| January 15, 2026 | The 2025 Annual General Meeting of Shareholders will be held at 9:00 a.m. PST. |
| February 25, 2026 November 19, 2026 | Period for sales under Mr. DenBaars' new Rule 10b5-1 trading arrangement. |
| March 31, 2026 | Current Goleta facility lease expires. |
| June 30, 2026 | Fiscal year end for which Rose, Snyder & Jacobs LLP are proposed as independent auditors. |
| July 25, 2026 | Deadline for submission of shareholder proposals for the 2026 Annual Meeting of Shareholders. |
| 2026 Annual Shareholder Meeting | Class II directors Craig Ensley and Michael Byron's terms expire. |
| 2027 Annual Shareholder Meeting | Class III director Jonathan Klamkin's term expires. |
| 2028 Annual Meeting | Class I directors Steven P. DenBaars and John Paglia's new terms expire (if elected). |
Recommendation
holdAeluma demonstrates strong revenue growth and has significantly bolstered its cash position through recent public offerings, which has alleviated immediate going concern risks. The company is actively securing government contracts and expanding its R&D and manufacturing capabilities, targeting high-growth markets. However, it continues to operate at a net loss, and the identified material weakness in internal controls requires diligent remediation. The semiconductor industry is highly competitive and cyclical, with inherent risks related to technology adoption, supply chain, and intellectual property. While the growth trajectory is positive, the company is still in early development stages with no volume production for its core offerings, and future profitability remains uncertain. A 'hold' recommendation is appropriate to observe the company's progress in commercializing its technology, achieving sustained profitability, and effectively addressing internal control deficiencies.
Keywords
Semiconductor, Photodetectors, Quantum Computing, AI, 5G/6G, SWIR, Photonics, SEC Filing, Annual Meeting, Corporate Governance, Capital Raise, Financial Results, NASDAQ, R&D, Government Contracts, Materials Science, Optoelectronics
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.